Phio Pharmaceuticals Corp (PHIO) - News Archive

In recent news, Phio Pharmaceuticals Corp (NASDAQ: PHIO), a clinical stage biotechnology company, has announced the appointment of a new Chief Financial Officer (CFO). This move comes as the company strives to improve i...

:This article explores the recent under-performance of Phio Pharmaceuticals Corp shares and provides an analysis of the factors contributing to this trend. The study examines the impact of various events, including the...

Phio Pharmaceuticals Corp, a clinical stage biotechnology company focused on developing innovative siRNA gene silencing technology, has recently made several significant announcements that underline their commitment to...

The recent breakthrough discovery of the effectiveness of Phios PH-762 in combating cancer cell growth has risen as an emblem of hope for individuals diagnosed with cancer. The application of the intratumoral injection...

Phio Pharmaceuticals, a leading pharmaceutical company, has recently announced the addition of three renowned clinical trial sites that are now actively participating in the Phase 1b study. The Banner MD Anderson Cancer...